Valuation Medivolve Deutsche Boerse AG
Stocks
4NC
CA58503M1014
Advanced Medical Equipment & Technology
|
End-of-day quote
Deutsche Boerse AG
2024-02-05
|
5-day change | 1st Jan Change | ||
| 0.003000 EUR | -.--% |
|
-80.00% | +500.00% |
| 05-11 | Osc reaches settlements with Stan Bharti and Neil Said, former executives of Medivolve Inc. | RE |
| 24-08-30 | Medivolve Inc. Announces Resignation of David Preiner as Chief Executive Officer | CI |
Company Valuation: Medivolve
Data adjusted to current consolidation scope
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 4.622 | 3.649 | 60.93 | 30.11 | 3.463 | 0.3889 |
| Change | - | -21.05% | 1,569.75% | -50.59% | -88.5% | -88.77% |
| Enterprise Value (EV) 1 | 0.2427 | 2.882 | 79.89 | 31.81 | 0.8181 | 1.054 |
| Change | - | 1,087.5% | 2,671.74% | -60.19% | -97.43% | 28.82% |
| P/E | -6.5x | -1.34x | -1.08x | -3.26x | -0.19x | -0.02x |
| PBR | 1.02x | 1.84x | -6.1x | 1.69x | 10.6x | -0.02x |
| PEG | - | -0x | -0x | 0x | -0x | 0x |
| Capitalization / Revenue | - | -36,724,139x | 5,757,519x | 346,766x | 93,154x | 566,592x |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | -0.26x | - | -9.89x | 2.75x | -0.04x | -0.32x |
| EV / EBIT | -0.26x | -1.18x | -9.75x | 3.01x | -0.04x | -0.31x |
| EV / FCF | -0.91x | -1.15x | 12.4x | -4.53x | 0.1x | 0.1x |
| FCF Yield | -110% | -87.3% | 8.04% | -22.1% | 1,010% | 1,028% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.3122 | -1.193 | -5.661 | -0.3421 | -0.6798 | -0.6091 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | -0.0994 | 10.58 | 86.82 | 37.18 | 0.6865 |
| EBITDA 1 | -0.9385 | - | -8.08 | 11.56 | -20.19 | -3.284 |
| EBIT 1 | -0.9401 | -2.435 | -8.191 | 10.56 | -20.32 | -3.411 |
| Net income 1 | -0.7116 | -2.718 | -37.78 | -6.611 | -18.37 | -16.46 |
| Net Debt 1 | -4.38 | -0.767 | 18.95 | 1.699 | -2.645 | 0.665 |
| Reference price 2 | 2.027978 | 1.601007 | 6.116156 | 1.114453 | 0.128169 | 0.014395 |
| Nbr of stocks (in thousands) | 2,279 | 2,279 | 9,963 | 27,016 | 27,019 | 27,019 |
| Announcement Date | 4/9/19 | 4/24/20 | 3/31/21 | 3/31/22 | 4/3/23 | 4/2/24 |
1CAD in Million2CAD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 42.97x | 10.4x | 22.93x | -.--% | 45.44B | |
| 89.81x | 48.8x | 61.96x | 0.59% | 11.81B | |
| 73.6x | 12.79x | 50.3x | 0.7% | 5.54B | |
| -65.14x | 16.54x | -108.31x | - | 4.28B | |
| -6.5x | 57.52x | -6.52x | - | 1.94B | |
| 34.23x | - | - | -.--% | 1.54B | |
| -119.08x | - | - | - | 1.01B | |
| 6.68x | - | - | - | 960M | |
| Average | 7.07x | 29.21x | 4.07x | 0.32% | 9.07B | |
| Weighted average by Cap. | 42.32x | 18.87x | 22.85x | 0.17% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MEDVF Stock
- 4NC Stock
- Valuation Medivolve
Select your edition
All financial news and data tailored to specific country editions
